Skip to main content
Log in

Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Substance P content was determined by radioimmunoassay in colonic mucosa from 24 patients with chronic severe constipation, 16 with active ulcerative colitis, and 28 normal controls. In patients with chronic severe constipation, the mean concentration of substance P (19.9±8.2 pg/mg) was significantly lower than in normal subjects (71±18 pg/mg). In patients with ulcerative colitis, colonic substance P concentration in inflamed mucosa (170±46 pg/mg) was significantly higher than its levels in normal subjects. Substance P may therefore have a role in the pathogenesis of clinical conditions associated with diarrhea and constipation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. De Vroede G: Constipation: Mechanisms and management.In Gastrointestinal Disease, 3rd ed., Vol 1. M Sleisenger, JS Fordtran (eds). Philadelphia, WB Saunders, 1983, p 288.

    Google Scholar 

  2. Haubrich WS: Constipation:In Bockus Gastroenterology, 4th ed., Vol 1. JE Berk (ed). Philadelphia, WB Saunders, 1985, p. 113

    Google Scholar 

  3. Bartho L, Holzer P: Search for a physiological role of substance P in gastrointestinal motility. Neuroscience 16:1–32, 1985

    PubMed  Google Scholar 

  4. Llewellyn-Smith IJ, Furness JB, Murphy R, O'Brien PE, Costa M: Substance P-containing nerves in the human small intestine. Gastroenterology 86:421–435, 1984

    PubMed  Google Scholar 

  5. McFadden D, Zinner MJ, Jaffe BM: Substance P-induced intestinal secretion of water and electrolytes. Gut 27:267–272, 1986

    PubMed  Google Scholar 

  6. Silkoff P, Karmeli F, Goldin E, Ewenson A, Gilon C, Chorev M, Laufer R, Selinger Z, Rachmilewitz D: Effect of substance P in rat gastrointestinal transit. Dig Dis Sci 33:74–77, 1988

    PubMed  Google Scholar 

  7. Konturek SJ, Jaworek J, Tasler J, Cieszdowski M, Pawlik W: Effect of substance P and its C-terminal hexapeptide on gastric and pancreatic secretion in dog. Am J Physiol 214: G74-G81, 1981

    Google Scholar 

  8. Laufer R, Ewenson A, Gilon C, Chorev M, Selinger Z: Inhibition of substance P degradation in rat brain preparation by peptide hydroxamic acids. Eur J Biochem 150:135–140, 1985

    PubMed  Google Scholar 

  9. Mantyh PW, Goedert M, Hunt SP: Autoradiographic visualization of receptor binding sites for substance P in the gastrointestinal tract of the guinea pig. Eur J Pharmacol 100: 133–134, 1984

    PubMed  Google Scholar 

  10. Bradin E, Sjolund K, Hakanson R, Sundler F: Substance P-containing nerve fibers are numerous in human but not in feline intestinal mucosa. Gastroenterology 85:557–564, 1983

    PubMed  Google Scholar 

  11. Martenson HG, Akande B, Yeo Ch, Jaffe BM: The role of substance P in the control of gastric acid secretion. Surgery 95:567–571, 1984

    PubMed  Google Scholar 

  12. Donnerer J, Bartho L, Holzer P, Lembeck F: Intestinal peristalsis associated with release of immunoreactive substance P. Neuroscience 11:913–918, 1984

    PubMed  Google Scholar 

  13. Holzer P, Lembeck F: Effect of neuropeptides on the efficiency of the peristaltic reflex. Naunyn-Schmiedeberg's Arch Pharmacol 307:257–264, 1979

    Google Scholar 

  14. Keast JR, Furness JB, Acosta M: Different substance P receptors are found on mucosal epithelial cells and submucous neurons of the guinea-pig small intestine. NaunynSchmiedeberg's Arch Pharmacol 329:382–387, 1985

    Google Scholar 

  15. Long RG, Barnes AJ, O'Snaughnessy DJ, Bannister R, Bishop AE, Albuquerque RH, McGregor GP, Polak JM, Bloom SR: Neural and hormonal peptides in rectal biopsy specimens from patients with Chagas' disease and chronic autonomic failure. Lancet 1:559–562, 1980

    PubMed  Google Scholar 

  16. Powel D, Cannon P, Skrabanek P, Kirrane J: The pathophysiology of substance P in man.In Gut Hormones. SR Bloom (ed). Edinburgh, Churchill Livingstone, 1978, pp 525–529

    Google Scholar 

  17. Domschke S, Adrian TE, Bloom SR, Lux G, Bryant MG, Domschke W: VIP, substance P and gastrin levels of gastroduodenal mucosa in celiac sprue. Gastroenterology 82: 1044, 1982 (abstract)

    Google Scholar 

  18. Sjolund K, Schafalitzky OBM, Fahrenkrug J, Hakanson R, Peterson BG, Sundler F: Peptide-containing nerve fibers in the gut wall in Crohn's disease. Gut 24:724–733, 1983

    PubMed  Google Scholar 

  19. Koch TR, Carney JA, Go VLW: Distribution and quantitation of gut peptides in normal colon and ulcerative colitis. Gastroenterology 86:1139, 1984 (abstract)

    Google Scholar 

  20. Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbaum AI: Intraneural substance P contributes to the severity of experimental arthritis. Science 226:547–549, 1984

    PubMed  Google Scholar 

  21. Reynolds JC, Ouyang A, Lee AC, Baker L, Sunshine AG, Cohen S: Chronic severe constipation. Gastroenterology 92: 414–420, 1987

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldin, E., Karmeli, F., Selinger, Z. et al. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Digest Dis Sci 34, 754–757 (1989). https://doi.org/10.1007/BF01540348

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01540348

Key words

Navigation